Parse Biosciences Expands Global Reach with the South Australian Genomics Centre as Certified Service Provider
The SAGC joins Parse’s network to meet rising demand for high-quality single cell solutions in Australia
Parse Biosciences, the leader in scalable and accessible single cell sequencing, is pleased to welcome the South Australian Genomics Centre (SAGC) as the newest member of its Certified Service Provider (CSP) Program. As a certified provider, the SAGC expands access to Parse’s pioneering single cell technology, equipping researchers across Australia and the broader Asia-Pacific region with the tools and expertise to accelerate discovery at scale.
Introduced in 2024, Parse’s CSP Program was created to connect researchers with trusted service providers for outsourcing single cell projects, ranging from small-scale exploratory studies to high-throughput, routine analyses. By maintaining rigorous standards, the program ensures providers deliver high-quality, scalable solutions that drive scientific discovery forward.
“We are thrilled to be the first Genomics Centre in Australasia to partner with Parse Biosciences as a Certified Service Provider. Their single cell technology has quickly gained traction amongst the Australian research community due to its scalability, sample fixation and cost-effectiveness,” said Dr. Sen Wang, SAGC Centre Manager.
"Expanding our Certified Service Provider Program is key to ensuring researchers have reliable access to high-quality single cell sequencing solutions," said Alex Rosenberg, CEO and co-founder of Parse Biosciences. "With the SAGC joining the program, scientists now have another trusted partner equipped to support projects of all sizes with the scalability and precision they need to drive discovery."
About the South Australian Genomics Centre (SAGC)
The SAGC is located in Adelaide, South Australia with labs in both the South Australian Health and Medical Research Institute (SAHMRI) and Flinders University. The SAGC is NATA accredited and offers a wide range of genomics and bioinformatics services (e.g., RNA, WGS, WES, epigenomics, metagenomics, single cell and spatial). The SAGC supports all areas of genomics (animal, plant, environmental, microbial, and human) and clients from academia, healthcare and industry.
For more information, please visit https://sa-genomics.com.au/
About Parse Biosciences
Parse Biosciences is a global life sciences company dedicated to accelerating advancements in human health and scientific research. By empowering researchers to conduct single cell sequencing with unparalleled scale and simplicity, Parse’s innovative solutions are driving breakthroughs in cancer treatment, tissue repair, stem cell therapy, and more.
Built upon transformative technology developed at the University of Washington, Parse Biosciences has raised over $100 million and is used by over 2,500 labs worldwide. Its expanding product portfolio includes Evercode Whole Transcriptome, Evercode TCR, Evercode BCR, CRISPR Detect, Gene Select, and Trailmaker for advanced data analysis.
Headquartered in Seattle’s vibrant South Lake Union district, Parse Biosciences recently inaugurated a 34,000-square-foot facility featuring state-of-the-art laboratories to support its mission of advancing global research.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250320291525/en/
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Novotech Welcomes New Investment From GIC, Temasek, and Existing Investor TPG to Accelerate Global Growth31.3.2025 05:00:00 CEST | Press release
Novotech, a globally recognized full-service biotech specialist clinical research organization (CRO), announced today that affiliates of GIC and Temasek have signed binding agreements to acquire a significant stake in the company, with the additional capital earmarked to accelerate its global growth. Existing investor TPG will also reinvest through its TPG Asia fund. Novotech, headquartered in Singapore with a global presence across more than 30 offices, is one of the world’s leading full-service clinical CROs, providing biotech and small- to mid-sized pharmaceutical companies with an accelerated path to market. Today, the company has a global footprint across the Asia-Pacific region, North America and Europe, and partnerships with more than 5,000 trial sites. Novotech has a leading position in the most innovative areas of clinical research such as cell and gene therapies, radiopharmaceuticals and mRNA trials. The reinvestment by TPG Asia and investment from GIC and Temasek will allow
VeriSilicon Introduces AcuityPercept: an AI-Powered Automatic ISP Tuning System31.3.2025 02:00:00 CEST | Press release
Intelligently optimizing ISP settings to seamlessly align with the target vision perception engines for superior object recognition VeriSilicon (688521.SH) today announced AcuityPercept, its AI-based automatic Image Signal Processing (ISP) tuning system, designed to intelligently optimize image processing parameters for enhanced object recognition. AcuityPercept improves the accuracy and efficiency of AI perception systems by dynamically optimizing ISP parameters through automated tuning processes. It is widely applicable to AI-powered vision applications across various industries, including autonomous driving, robotic vision, and AIoT. VeriSilicon’s AcuityPercept leverages a global directive and local refinement algorithm, utilizing metadata and loss feedback from AI task models to automatically achieve optimal ISP tuning. By continuously refining ISP settings, it effectively enhances object detection accuracy and delivers optimal ISP-processed images for neural network processing. Ac
SLB Announces First-Quarter 2025 Results Conference Call28.3.2025 18:01:00 CET | Press release
SLB (NYSE: SLB) will hold a conference call on April 25, 2025 to discuss the results for the first quarter ending March 31, 2025. The conference call is scheduled to begin at 9:30 am US Eastern time and a press release regarding the results will be issued at 7:00 am US Eastern time. To access the conference call, listeners should contact the Conference Call Operator at +1 (833) 470-1428 within North America or +1 (404) 975-4839 outside of North America approximately 10 minutes prior to the start of the call and the access code is 114893. A webcast of the conference call will be broadcast simultaneously at https://events.q4inc.com/attendee/581727555 on a listen-only basis. Listeners should log in 15 minutes prior to the start of the call to test their browsers and register for the webcast. Following the end of the conference call, a replay will be available at www.slb.com/irwebcast until May 2, 2025, and can be accessed by dialing +1 (866) 813-9403 within North America or +1 (929) 458-6
Andersen Global udvider canadisk platform med MMCA & Associates LLP28.3.2025 16:36:00 CET | Pressemeddelelse
Andersen Global styker sin canadiske platform ved en samarbejdsaftele med MMCA & Associates LLP, et revisionsfirma med fuld servicepakke, der føjer yderligere kapacitet til tilstedeværelsen i landet. MMCA & Associates LLP, der har hovedkontor i Calgary, har også kontorer i Edmonton og Banff. Firmaet er specialister i skatterådgivning og overholdelse af skatteregler. Firmaet er leveringsdygtig inden for blandt andet bistand ved udfyldelse af selvangivelser for såvel virksomheder som private, bo- og arveplanlægning samt forsikrings- og bogføring. Kundekredsen omfatter en bred vifte af brancher. "Vi er stolte af at kunne levere skattemæssig bistand, samtidig med at vi hjælper kunderne med effektivt at styre deres økonomiske resultater i retning af deres forretningsmål," siger partner Dorin Bogdan Mihalache. "Via samarbejdet med Andersen Global har vi mulighed for at bygge oven på egne ressourcer og egen formåen, hvorved vi bliver bedre i stand til at betjene kunderne lokalt og internation
Presidio Investors Welcomes Wynee Sade as Newest Operating Partner28.3.2025 16:32:00 CET | Press release
Presidio Investors is pleased to announce the addition of Wynee Sade as its newest Operating Partner. With over 25 years of global sales and marketing experience, Wynee has held senior leadership roles across a range of industries, including Chief Marketing Officer at Forager Project and leadership positions at Qooco, AppSymth, and Shopkick. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250327178560/en/ Wynee Sade, Presidio Investors Operating Partner Wynee’s expertise in driving growth, building brands, and leading high-performing teams has shaped organizations from early-stage startups to established Fortune 500 companies. She has a proven track record of scaling businesses and delivering impactful solutions. Wynee is also the founder of Yu Ming Charter School, California’s first public K-8 Mandarin immersion school, which has earned numerous accolades, including National Blue Ribbon recognition. Wynee holds an MBA from H
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom